Report error Found 8 Enz. Inhib. hit(s) with all data for entry = 12366
TargetShort transient receptor potential channel 5(Human)
WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD.
US Patent
WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD.
US Patent
Affinity DataIC50: 6.52nMAssay Description:TRPC5 is a type of non-selective cation channel with permeability to calcium ions. Therefore, TRPC5 agonist Englerin A (EA) and TRPC5 inhibitor Pico1...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Human)
WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD.
US Patent
WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD.
US Patent
Affinity DataIC50: 7.37nMAssay Description:TRPC5 is a type of non-selective cation channel with permeability to calcium ions. Therefore, TRPC5 agonist Englerin A (EA) and TRPC5 inhibitor Pico1...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Human)
WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD.
US Patent
WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD.
US Patent
Affinity DataIC50: 10.8nMAssay Description:TRPC5 is a type of non-selective cation channel with permeability to calcium ions. Therefore, TRPC5 agonist Englerin A (EA) and TRPC5 inhibitor Pico1...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Human)
WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD.
US Patent
WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD.
US Patent
Affinity DataIC50: 11.5nMAssay Description:TRPC5 is a type of non-selective cation channel with permeability to calcium ions. Therefore, TRPC5 agonist Englerin A (EA) and TRPC5 inhibitor Pico1...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Human)
WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD.
US Patent
WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD.
US Patent
Affinity DataIC50: 14.6nMAssay Description:TRPC5 is a type of non-selective cation channel with permeability to calcium ions. Therefore, TRPC5 agonist Englerin A (EA) and TRPC5 inhibitor Pico1...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Human)
WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD.
US Patent
WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD.
US Patent
Affinity DataIC50: 18.2nMAssay Description:TRPC5 is a type of non-selective cation channel with permeability to calcium ions. Therefore, TRPC5 agonist Englerin A (EA) and TRPC5 inhibitor Pico1...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Human)
WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD.
US Patent
WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD.
US Patent
Affinity DataIC50: 24nMAssay Description:TRPC5 is a type of non-selective cation channel with permeability to calcium ions. Therefore, TRPC5 agonist Englerin A (EA) and TRPC5 inhibitor Pico1...More data for this Ligand-Target Pair
TargetShort transient receptor potential channel 5(Human)
WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD.
US Patent
WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD.
US Patent
Affinity DataIC50: 39.4nMAssay Description:TRPC5 is a type of non-selective cation channel with permeability to calcium ions. Therefore, TRPC5 agonist Englerin A (EA) and TRPC5 inhibitor Pico1...More data for this Ligand-Target Pair
